2 days ago - The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment access to more patients.

4 hours ago - On Dec.22, the Wegovy manufacturer became the first drugmaker to win FDA approval for a GLP-1 pill for weight loss, a milestone some analysts called a “redemption for investors” following the stock’s worst year on record.

5 hours ago - Sign up here. The U.S. Food and Drug Administration approved Novo Nordisk's (NOVOb.CO), opens new tab Wegovy GLP-1 pill on Monday, sending shares of food companies down on Tuesday.

1 day ago - ... A 64-week, late-stage study showed participants who took the 25 mg of oral semaglutide once daily lost an average of 16.6% of their body weight, compared with 2.7% for those on a placebo. The injectable version of Wegovy won FDA approval in 2021 ...

1 day ago - The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs.

4 hours ago - The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events.

1 day ago - On Monday, the Food and Drug Administration approved a pill version of Wegovy, Novo Nordisk’s wildly popular weight loss drug, officially launching the first oral GLP-1 medication ever cleared for obesity treatment.

1 day ago - Novo Nordisk says Wegovy pill approved in U.S. as oral GLP-1, Bloomberg reports · Novo Nordisk says FDA approved Wegovy pill to reduce body weight

The first and only FDA-approved GLP-1 pill to help adults with obesity lose weight and keep it off along with diet and exercise.

1 day ago - U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s approval handed drugmaker Novo Nordisk an ...

1 day ago - Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment option for patients with obesity or overweight. Clinical trials, such as OASIS 4, showed the pill's efficacy, with ...

2 days ago - The FDA approves Wegovy's oral pill for weight loss, offering a new alternative to injections. Learn about its effectiveness, cost, and competition with Eli Lilly's oral drug.

2 days ago - Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Novo Nordisk's (NOVOb.CO), opens new tab weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as ...

2 days ago - Novo Nordisk shares are trading higher Tuesday following approval of its Wegovy GLP-1 pill by the Food and Drug Administration

November 11, 2025 - FDA Approved: Yes (First approved June 4, 2021) Brand name: Wegovy Generic name: semaglutide Dosage form: Injection Company: Novo Nordisk Treatment for: Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction, Nonalcoholic Steatohepatitis

2 days ago - "The FDA approval of Wegovy pill -- the first oral GLP-1 for adults with obesity and overweight with weight-related medical problems -- has the potential to impact millions of Americans," Dave Moore, executive vice president of Novo Nordisk ...